Axa’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-89,521
| Closed | -$9.59M | – | 1186 |
|
|
2021
Q4 | $9.59M | Sell |
89,521
-20,700
| -19% | -$2.22M | 0.02% | 502 |
|
|
2021
Q3 | $11.3M | Buy |
110,221
+12,328
| +13% | +$1.27M | 0.03% | 461 |
|
|
2021
Q2 | $8.61M | Sell |
97,893
-7,438
| -7% | -$654K | 0.02% | 555 |
|
|
2021
Q1 | $10.2M | Buy |
105,331
+1,958
| +2% | +$190K | 0.03% | 511 |
|
|
2020
Q4 | $11.6M | Buy |
103,373
+2,900
| +3% | +$325K | 0.04% | 474 |
|
|
2020
Q3 | $9.31M | Sell |
100,473
-992
| -1% | -$92K | 0.03% | 478 |
|
|
2020
Q2 | $7.91M | Buy |
101,465
+45,847
| +82% | +$3.58M | 0.03% | 495 |
|
|
2020
Q1 | $3.25M | Buy |
+55,618
| New | +$3.25M | 0.02% | 631 |
|
|
2019
Q4 | – | Sell |
-107,575
| Closed | -$7.9M | – | 1179 |
|
|
2019
Q3 | $7.9M | Sell |
107,575
-161
| -0.1% | -$11.8K | 0.03% | 534 |
|
|
2019
Q2 | $10.2M | Sell |
107,736
-18,054
| -14% | -$1.7M | 0.04% | 472 |
|
|
2019
Q1 | $10.1M | Buy |
125,790
+95,386
| +314% | +$7.64M | 0.04% | 457 |
|
|
2018
Q4 | $1.64M | Hold |
30,404
| – | – | 0.01% | 863 |
|
|
2018
Q3 | $2.37M | Sell |
30,404
-8,500
| -22% | -$663K | 0.01% | 842 |
|
|
2018
Q2 | $2.47M | Buy |
38,904
+27,604
| +244% | +$1.75M | 0.01% | 805 |
|
|
2018
Q1 | $1.04M | Sell |
11,300
-1,500
| -12% | -$138K | ﹤0.01% | 995 |
|
|
2017
Q4 | $965K | Buy |
12,800
+3,300
| +35% | +$249K | ﹤0.01% | 1009 |
|
|
2017
Q3 | $662K | Buy |
+9,500
| New | +$662K | ﹤0.01% | 1054 |
|